Tag: product

REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deducting the underwriting discounts and commissions and offering expenses, the aggregate gross proceeds to the Company were approximately $98 million.

Attachment

MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B for injection) followed by standard of care (SOC) in patients with invasive aspergillosis whose infection is either refractory to or unsuitable for azole therapy.

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- GROWNSY, a baby care innovator trusted by more than 3 million households worldwide, today announced its full Amazon Prime Day 2026 strategy under the campaign theme "Baby Grows. Feeding Grows." This year's Prime Day, confirmed by Amazon as a June event across 26 countries including the United States, United Kingdom, Canada, Germany, France, Italy, and Spain, represents the earliest and most significant mid-year shopping window in the platform's history. GROWNSY is treating it as exactly that: not a routine promotion, but a pivotal moment to meet parents where they are.